ADVERTISEMENT
search.svg

Pharmacy News

FDA: Don’t use antibody testing to evaluate immunity after COVID-19 vaccination

FDA reminded health care professionals and the public that results from currently authorized COVID-19 antibody tests should not be used to assess a person’s level of immunity or protection from COVID-19 at any time, particularly after the person has received a COVID-19 vaccination.

Oregon pays pharmacists for all services under scope of practice

Alis Volat Propriis—“She flies with her own wings”—is Oregon’s state motto. The government first adopted the slogan in 1854 as a hat tip to the independent spirit of the pioneers who formed Oregon’s first government. The slogan was replaced by others over the years until lawmakers brought it back in 1987—arguing that it still reflected Oregon’s traditions of independence and innovation.

Preventing VTE in critically ill COVID-19 patients

Venous thromboembolism (VTE) is the most commonly reported thrombotic complication of COVID-19, with approximately 28% of critically ill patients with COVID-19 experiencing VTE. However, limited data are available to guide the intensity of antithrombotic prophylaxis.

Dexamethasone appears safe in preventing postsurgery nausea

Although dexamethasone is often used to prevent nausea and vomiting after surgery, concerns have been raised that it may increase the risk of surgical-site infection. A new study from researchers in New Zealand and Australia published on May 6 in the New England Journal of Medicine showed that dexamethasone was noninferior to placebo in the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery.  

Do adolescents have better HPV vaccination rates than young adults?

Researchers from the University of Michigan examined vaccination against human papillomavirus (HPV) in young adults versus adolescents for an 8-year period, from 2010 to 2018. Regardless of what age they were at first dose, more survey respondents opted for vaccination as the years passed. Still, compared with adolescents—68% of whom received one or more HPV doses by 2018—overall takeup among young adults was low.

RSS
First45679111213Last